{"DataElement":{"publicId":"5544952","version":"1","preferredName":"Renal Cell Carcinoma Stratification Factor Histologic Category","preferredDefinition":"Selected pre-treatment factors by which patients are segregated before randomization to an intervention arm of a renal cell carcinoma clinical protocol based on defined characteristics of combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","longName":"5544739v1.0:5544949v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"5544739","version":"1","preferredName":"Renal Cell Carcinoma Stratification Factors","preferredDefinition":"The most common type of kidney cancer. It begins in the lining of the renal tubules in the kidney. The renal tubules filter the blood and produce urine._Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","longName":"2428360v1.0:5544737v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"2428360","version":"1","preferredName":"Renal Cell Carcinoma","preferredDefinition":"Cancer that develops in the lining of the renal tubules, which filter the blood and produce urine.","longName":"C9385","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Cell Carcinoma","conceptCode":"C9385","definition":"A carcinoma arising from the renal parenchyma.  There is a strong correlation between cigarette smoking and the development of renal cell carcinoma.  The clinical presentation includes : hematuria, flank pain and a palpable lumbar mass.  A high percentage of renal cell carcinomas are diagnosed when an ultrasound is performed for other purposes.  Radical nephrectomy is the standard intervention procedure.  Renal cell carcinoma is generally considered to be resistant to radiation treatment and chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0826-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5544737","version":"1","preferredName":"Stratification Factors","preferredDefinition":"Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","longName":"C16153","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stratification Factors","conceptCode":"C16153","definition":"Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FD8CA83-7B2E-5DA4-E053-F662850AFE65","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"ONEDATA","dateModified":"2016-10-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FD8CA83-7B3F-5DA4-E053-F662850AFE65","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeDescription":"Created for EA8143, JG 10/27/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5544949","version":"1","preferredName":"Histologic Category","preferredDefinition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._A grouping of items based on some commonality or by user defined characteristics.","longName":"5544949v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3FDAFDAC-3160-43A4-E053-F662850A5B6B","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"ONEDATA","dateModified":"2016-10-27","deletedIndicator":"No"},{"value":"Non-clear cell carcinoma (including unclassified)","valueDescription":"Negation Clear Cell Adenocarcinoma Include Unclassified","ValueMeaning":{"publicId":"5544950","version":"1","preferredName":"Negation Clear Cell Adenocarcinoma Include Unclassified","longName":"5544950","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: A malignant neoplasm composed of glandular epithelial clear cells.  Various architectural patterns may be seen, including papillary, tubulocystic, and solid.: Add as part of something else; put in as part of a set, group, or category.: Not arranged or included in any specific grouping.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clear Cell Adenocarcinoma","conceptCode":"C3766","definition":"A malignant neoplasm composed of glandular epithelial clear cells.  Various architectural patterns may be seen, including papillary, tubulocystic, and solid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Include","conceptCode":"C74521","definition":"Add as part of something else; put in as part of a set, group, or category.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Unclassified","conceptCode":"C64486","definition":"Not arranged or included in any specific grouping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FDAFDAC-316F-43A4-E053-F662850A5B6B","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3FDAFDAC-318A-43A4-E053-F662850A5B6B","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"ONEDATA","dateModified":"2016-10-27","deletedIndicator":"No"},{"value":"Clear cell carcinoma (>50%)","valueDescription":"Clear Cell Adenocarcinoma Greater Than Fifty Percent Unit","ValueMeaning":{"publicId":"5544951","version":"1","preferredName":"Clear Cell Adenocarcinoma Greater Than Fifty Percent Unit","longName":"5544951","preferredDefinition":"A malignant neoplasm composed of glandular epithelial clear cells.  Various architectural patterns may be seen, including papillary, tubulocystic, and solid.: A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A natural number greater than forty-nine and less than fifty-one and the quantity that it denotes.: A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Adenocarcinoma","conceptCode":"C3766","definition":"A malignant neoplasm composed of glandular epithelial clear cells.  Various architectural patterns may be seen, including papillary, tubulocystic, and solid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Fifty","conceptCode":"C105785","definition":"A natural number greater than forty-nine and less than fifty-one and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Percent Unit","conceptCode":"C48570","definition":"A unit for expressing a number as a fraction of hundred (on the basis of a rate or proportion per hundred).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FDAFDAC-3199-43A4-E053-F662850A5B6B","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3FDAFDAC-31B4-43A4-E053-F662850A5B6B","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"ONEDATA","dateModified":"2016-10-27","deletedIndicator":"No"},{"value":"Clear cell","valueDescription":null,"ValueMeaning":{"publicId":"4039074","version":"1","preferredName":"Clear Cell Adenocarcinoma","longName":"4039074","preferredDefinition":"A malignant neoplasm composed of glandular epithelial clear cells.  Various architectural patterns may be seen, including papillary, tubulocystic, and solid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Adenocarcinoma","conceptCode":"C3766","definition":"A malignant neoplasm composed of glandular epithelial clear cells.  Various architectural patterns may be seen, including papillary, tubulocystic, and solid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EEFFA5EA-68A2-E8CD-E040-BB89AD4345DA","latestVersionIndicator":"Yes","beginDate":"2014-01-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-01-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FA4007A9-A5D1-45D9-E053-731AD00AF366","beginDate":"2023-04-26","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-04-26","modifiedBy":"FINCHAMB","dateModified":"2023-04-26","deletedIndicator":"No"},{"value":"Non-clear cell","valueDescription":null,"ValueMeaning":{"publicId":"13441142","version":"1","preferredName":"Negation Clear Cell Adenocarcinoma","longName":"13441142v1.00","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction._A malignant neoplasm composed of glandular epithelial clear cells.  Various architectural patterns may be seen, including papillary, tubulocystic, and solid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clear Cell Adenocarcinoma","conceptCode":"C3766","definition":"A malignant neoplasm composed of glandular epithelial clear cells.  Various architectural patterns may be seen, including papillary, tubulocystic, and solid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FA4007A9-A5D0-45D9-E053-731AD00AF366","latestVersionIndicator":"Yes","beginDate":"2023-04-26","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-04-26","modifiedBy":"FINCHAMB","dateModified":"2023-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FA4007A9-A5D2-45D9-E053-731AD00AF366","beginDate":"2023-04-26","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-04-26","modifiedBy":"FINCHAMB","dateModified":"2023-04-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208105","version":"1","preferredName":"Histologic Category","preferredDefinition":"Of or relating to histology.:Category; used informally to mean a class of things.","longName":"C25526:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3D9A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FDAFDAC-3149-43A4-E053-F662850A5B6B","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"FINCHAMB","dateModified":"2023-04-26","changeDescription":"Created for EA8143. JG 10/27/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"10000047","version":"1","longName":"Pathology","context":"ECOG-ACRIN"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Histology","type":"Preferred Question Text","description":"Histology","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FDB0CB2-F854-6185-E053-F662850A29D4","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"GARRIDOJ","dateModified":"2017-04-26","changeDescription":"Created for EA8143, JG 10/27/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}